イマチニブメシル酸塩錠のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Imatinib Mesylate Tablets Market Insights, Forecast to 2028

• レポートコード：QY2207E10381 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のイマチニブメシル酸塩錠の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にイマチニブメシル酸塩錠の世界市場のxxx％を占める「100mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のイマチニブメシル酸塩錠の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのイマチニブメシル酸塩錠市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのイマチニブメシル酸塩錠市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 イマチニブメシル酸塩錠のグローバル主要メーカーには、Teva Pharmaceuticals、Hikma Pharmaceuticals、Apotex Inc、Sun Pharmaceutical Industries、Lupin Limited、Natco Pharma、Getwell Oncologyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 イマチニブメシル酸塩錠市場は、種類と用途によって区分されます。世界のイマチニブメシル酸塩錠市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 100mg、400mg 【用途別セグメント】 病院、クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - イマチニブメシル酸塩錠製品概要 - 種類別市場（100mg、400mg） - 用途別市場（病院、クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界のイマチニブメシル酸塩錠販売量予測2017-2028 - 世界のイマチニブメシル酸塩錠売上予測2017-2028 - イマチニブメシル酸塩錠の地域別販売量 - イマチニブメシル酸塩錠の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別イマチニブメシル酸塩錠販売量 - 主要メーカー別イマチニブメシル酸塩錠売上 - 主要メーカー別イマチニブメシル酸塩錠価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（100mg、400mg） - イマチニブメシル酸塩錠の種類別販売量 - イマチニブメシル酸塩錠の種類別売上 - イマチニブメシル酸塩錠の種類別価格 ・用途別市場規模（病院、クリニック） - イマチニブメシル酸塩錠の用途別販売量 - イマチニブメシル酸塩錠の用途別売上 - イマチニブメシル酸塩錠の用途別価格 ・北米市場 - 北米のイマチニブメシル酸塩錠市場規模（種類別、用途別） - 主要国別のイマチニブメシル酸塩錠市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのイマチニブメシル酸塩錠市場規模（種類別、用途別） - 主要国別のイマチニブメシル酸塩錠市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のイマチニブメシル酸塩錠市場規模（種類別、用途別） - 主要国別のイマチニブメシル酸塩錠市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のイマチニブメシル酸塩錠市場規模（種類別、用途別） - 主要国別のイマチニブメシル酸塩錠市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのイマチニブメシル酸塩錠市場規模（種類別、用途別） - 主要国別のイマチニブメシル酸塩錠市場規模（トルコ、サウジアラビア） ・企業情報 Teva Pharmaceuticals、Hikma Pharmaceuticals、Apotex Inc、Sun Pharmaceutical Industries、Lupin Limited、Natco Pharma、Getwell Oncology ・産業チェーン及び販売チャネル分析 - イマチニブメシル酸塩錠の産業チェーン分析 - イマチニブメシル酸塩錠の原材料 - イマチニブメシル酸塩錠の生産プロセス - イマチニブメシル酸塩錠の販売及びマーケティング - イマチニブメシル酸塩錠の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - イマチニブメシル酸塩錠の産業動向 - イマチニブメシル酸塩錠のマーケットドライバー - イマチニブメシル酸塩錠の課題 - イマチニブメシル酸塩錠の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Imatinib Mesylate Tablets Market
The global Imatinib Mesylate Tablets market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, 100 mg accounting for % of the Imatinib Mesylate Tablets global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Imatinib Mesylate Tablets market size is valued at US$ million in 2021, while the North America and Europe Imatinib Mesylate Tablets are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Imatinib Mesylate Tablets landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Imatinib Mesylate Tablets market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Imatinib Mesylate Tablets market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Imatinib Mesylate Tablets market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Imatinib Mesylate Tablets market.
Global Imatinib Mesylate Tablets Scope and Market Size
Imatinib Mesylate Tablets market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Imatinib Mesylate Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100 mg
400 mg
Segment by Application
Hospital
Clinics
By Company
Teva Pharmaceuticals
Hikma Pharmaceuticals
Apotex Inc
Sun Pharmaceutical Industries
Lupin Limited
Natco Pharma
Getwell Oncology
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imatinib Mesylate Tablets Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100 mg
1.2.3 400 mg
1.3 Market by Application
1.3.1 Global Imatinib Mesylate Tablets Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Imatinib Mesylate Tablets Market Perspective (2017-2028)
2.2 Imatinib Mesylate Tablets Growth Trends by Region
2.2.1 Imatinib Mesylate Tablets Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Imatinib Mesylate Tablets Historic Market Size by Region (2017-2022)
2.2.3 Imatinib Mesylate Tablets Forecasted Market Size by Region (2023-2028)
2.3 Imatinib Mesylate Tablets Market Dynamics
2.3.1 Imatinib Mesylate Tablets Industry Trends
2.3.2 Imatinib Mesylate Tablets Market Drivers
2.3.3 Imatinib Mesylate Tablets Market Challenges
2.3.4 Imatinib Mesylate Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imatinib Mesylate Tablets Players by Revenue
3.1.1 Global Top Imatinib Mesylate Tablets Players by Revenue (2017-2022)
3.1.2 Global Imatinib Mesylate Tablets Revenue Market Share by Players (2017-2022)
3.2 Global Imatinib Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imatinib Mesylate Tablets Revenue
3.4 Global Imatinib Mesylate Tablets Market Concentration Ratio
3.4.1 Global Imatinib Mesylate Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imatinib Mesylate Tablets Revenue in 2021
3.5 Imatinib Mesylate Tablets Key Players Head office and Area Served
3.6 Key Players Imatinib Mesylate Tablets Product Solution and Service
3.7 Date of Enter into Imatinib Mesylate Tablets Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imatinib Mesylate Tablets Breakdown Data by Type
4.1 Global Imatinib Mesylate Tablets Historic Market Size by Type (2017-2022)
4.2 Global Imatinib Mesylate Tablets Forecasted Market Size by Type (2023-2028)
5 Imatinib Mesylate Tablets Breakdown Data by Application
5.1 Global Imatinib Mesylate Tablets Historic Market Size by Application (2017-2022)
5.2 Global Imatinib Mesylate Tablets Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Imatinib Mesylate Tablets Market Size (2017-2028)
6.2 North America Imatinib Mesylate Tablets Market Size by Type
6.2.1 North America Imatinib Mesylate Tablets Market Size by Type (2017-2022)
6.2.2 North America Imatinib Mesylate Tablets Market Size by Type (2023-2028)
6.2.3 North America Imatinib Mesylate Tablets Market Share by Type (2017-2028)
6.3 North America Imatinib Mesylate Tablets Market Size by Application
6.3.1 North America Imatinib Mesylate Tablets Market Size by Application (2017-2022)
6.3.2 North America Imatinib Mesylate Tablets Market Size by Application (2023-2028)
6.3.3 North America Imatinib Mesylate Tablets Market Share by Application (2017-2028)
6.4 North America Imatinib Mesylate Tablets Market Size by Country
6.4.1 North America Imatinib Mesylate Tablets Market Size by Country (2017-2022)
6.4.2 North America Imatinib Mesylate Tablets Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Imatinib Mesylate Tablets Market Size (2017-2028)
7.2 Europe Imatinib Mesylate Tablets Market Size by Type
7.2.1 Europe Imatinib Mesylate Tablets Market Size by Type (2017-2022)
7.2.2 Europe Imatinib Mesylate Tablets Market Size by Type (2023-2028)
7.2.3 Europe Imatinib Mesylate Tablets Market Share by Type (2017-2028)
7.3 Europe Imatinib Mesylate Tablets Market Size by Application
7.3.1 Europe Imatinib Mesylate Tablets Market Size by Application (2017-2022)
7.3.2 Europe Imatinib Mesylate Tablets Market Size by Application (2023-2028)
7.3.3 Europe Imatinib Mesylate Tablets Market Share by Application (2017-2028)
7.4 Europe Imatinib Mesylate Tablets Market Size by Country
7.4.1 Europe Imatinib Mesylate Tablets Market Size by Country (2017-2022)
7.4.2 Europe Imatinib Mesylate Tablets Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imatinib Mesylate Tablets Market Size (2017-2028)
8.2 Asia-Pacific Imatinib Mesylate Tablets Market Size by Type
8.2.1 Asia-Pacific Imatinib Mesylate Tablets Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Imatinib Mesylate Tablets Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Imatinib Mesylate Tablets Market Share by Type (2017-2028)
8.3 Asia-Pacific Imatinib Mesylate Tablets Market Size by Application
8.3.1 Asia-Pacific Imatinib Mesylate Tablets Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Imatinib Mesylate Tablets Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Imatinib Mesylate Tablets Market Share by Application (2017-2028)
8.4 Asia-Pacific Imatinib Mesylate Tablets Market Size by Region
8.4.1 Asia-Pacific Imatinib Mesylate Tablets Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Imatinib Mesylate Tablets Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Imatinib Mesylate Tablets Market Size (2017-2028)
9.2 Latin America Imatinib Mesylate Tablets Market Size by Type
9.2.1 Latin America Imatinib Mesylate Tablets Market Size by Type (2017-2022)
9.2.2 Latin America Imatinib Mesylate Tablets Market Size by Type (2023-2028)
9.2.3 Latin America Imatinib Mesylate Tablets Market Share by Type (2017-2028)
9.3 Latin America Imatinib Mesylate Tablets Market Size by Application
9.3.1 Latin America Imatinib Mesylate Tablets Market Size by Application (2017-2022)
9.3.2 Latin America Imatinib Mesylate Tablets Market Size by Application (2023-2028)
9.3.3 Latin America Imatinib Mesylate Tablets Market Share by Application (2017-2028)
9.4 Latin America Imatinib Mesylate Tablets Market Size by Country
9.4.1 Latin America Imatinib Mesylate Tablets Market Size by Country (2017-2022)
9.4.2 Latin America Imatinib Mesylate Tablets Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imatinib Mesylate Tablets Market Size (2017-2028)
10.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type
10.2.1 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Imatinib Mesylate Tablets Market Share by Type (2017-2028)
10.3 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application
10.3.1 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Imatinib Mesylate Tablets Market Share by Application (2017-2028)
10.4 Middle East & Africa Imatinib Mesylate Tablets Market Size by Country
10.4.1 Middle East & Africa Imatinib Mesylate Tablets Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Imatinib Mesylate Tablets Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Details
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Introduction
11.1.4 Teva Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.1.5 Teva Pharmaceuticals Recent Developments
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Details
11.2.2 Hikma Pharmaceuticals Business Overview
11.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Introduction
11.2.4 Hikma Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.2.5 Hikma Pharmaceuticals Recent Developments
11.3 Apotex Inc
11.3.1 Apotex Inc Company Details
11.3.2 Apotex Inc Business Overview
11.3.3 Apotex Inc Imatinib Mesylate Tablets Introduction
11.3.4 Apotex Inc Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.3.5 Apotex Inc Recent Developments
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Details
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.4.5 Sun Pharmaceutical Industries Recent Developments
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Imatinib Mesylate Tablets Introduction
11.5.4 Lupin Limited Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.5.5 Lupin Limited Recent Developments
11.6 Natco Pharma
11.6.1 Natco Pharma Company Details
11.6.2 Natco Pharma Business Overview
11.6.3 Natco Pharma Imatinib Mesylate Tablets Introduction
11.6.4 Natco Pharma Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.6.5 Natco Pharma Recent Developments
11.7 Getwell Oncology
11.7.1 Getwell Oncology Company Details
11.7.2 Getwell Oncology Business Overview
11.7.3 Getwell Oncology Imatinib Mesylate Tablets Introduction
11.7.4 Getwell Oncology Revenue in Imatinib Mesylate Tablets Business (2017-2022)
11.7.5 Getwell Oncology Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Imatinib Mesylate Tablets Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of 100 mg
Table 3. Key Players of 400 mg
Table 4. Global Imatinib Mesylate Tablets Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Imatinib Mesylate Tablets Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Imatinib Mesylate Tablets Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Imatinib Mesylate Tablets Market Share by Region (2017-2022)
Table 8. Global Imatinib Mesylate Tablets Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Imatinib Mesylate Tablets Market Share by Region (2023-2028)
Table 10. Imatinib Mesylate Tablets Market Trends
Table 11. Imatinib Mesylate Tablets Market Drivers
Table 12. Imatinib Mesylate Tablets Market Challenges
Table 13. Imatinib Mesylate Tablets Market Restraints
Table 14. Global Imatinib Mesylate Tablets Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Imatinib Mesylate Tablets Revenue Share by Players (2017-2022)
Table 16. Global Top Imatinib Mesylate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Tablets as of 2021)
Table 17. Ranking of Global Top Imatinib Mesylate Tablets Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Imatinib Mesylate Tablets Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Imatinib Mesylate Tablets Product Solution and Service
Table 21. Date of Enter into Imatinib Mesylate Tablets Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Imatinib Mesylate Tablets Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Imatinib Mesylate Tablets Revenue Market Share by Type (2017-2022)
Table 25. Global Imatinib Mesylate Tablets Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Imatinib Mesylate Tablets Revenue Market Share by Type (2023-2028)
Table 27. Global Imatinib Mesylate Tablets Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Imatinib Mesylate Tablets Revenue Share by Application (2017-2022)
Table 29. Global Imatinib Mesylate Tablets Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Imatinib Mesylate Tablets Revenue Share by Application (2023-2028)
Table 31. North America Imatinib Mesylate Tablets Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Imatinib Mesylate Tablets Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Imatinib Mesylate Tablets Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Imatinib Mesylate Tablets Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Imatinib Mesylate Tablets Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Imatinib Mesylate Tablets Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Imatinib Mesylate Tablets Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Imatinib Mesylate Tablets Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Imatinib Mesylate Tablets Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Imatinib Mesylate Tablets Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Imatinib Mesylate Tablets Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Imatinib Mesylate Tablets Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Imatinib Mesylate Tablets Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Imatinib Mesylate Tablets Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Imatinib Mesylate Tablets Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Imatinib Mesylate Tablets Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Imatinib Mesylate Tablets Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Imatinib Mesylate Tablets Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Imatinib Mesylate Tablets Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Imatinib Mesylate Tablets Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Imatinib Mesylate Tablets Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Imatinib Mesylate Tablets Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Imatinib Mesylate Tablets Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Imatinib Mesylate Tablets Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Imatinib Mesylate Tablets Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Imatinib Mesylate Tablets Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Imatinib Mesylate Tablets Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Imatinib Mesylate Tablets Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Imatinib Mesylate Tablets Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Imatinib Mesylate Tablets Market Size by Country (2023-2028) & (US$ Million)
Table 61. Teva Pharmaceuticals Company Details
Table 62. Teva Pharmaceuticals Business Overview
Table 63. Teva Pharmaceuticals Imatinib Mesylate Tablets Product
Table 64. Teva Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 65. Teva Pharmaceuticals Recent Developments
Table 66. Hikma Pharmaceuticals Company Details
Table 67. Hikma Pharmaceuticals Business Overview
Table 68. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product
Table 69. Hikma Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 70. Hikma Pharmaceuticals Recent Developments
Table 71. Apotex Inc Company Details
Table 72. Apotex Inc Business Overview
Table 73. Apotex Inc Imatinib Mesylate Tablets Product
Table 74. Apotex Inc Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 75. Apotex Inc Recent Developments
Table 76. Sun Pharmaceutical Industries Company Details
Table 77. Sun Pharmaceutical Industries Business Overview
Table 78. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product
Table 79. Sun Pharmaceutical Industries Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 80. Sun Pharmaceutical Industries Recent Developments
Table 81. Lupin Limited Company Details
Table 82. Lupin Limited Business Overview
Table 83. Lupin Limited Imatinib Mesylate Tablets Product
Table 84. Lupin Limited Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 85. Lupin Limited Recent Developments
Table 86. Natco Pharma Company Details
Table 87. Natco Pharma Business Overview
Table 88. Natco Pharma Imatinib Mesylate Tablets Product
Table 89. Natco Pharma Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 90. Natco Pharma Recent Developments
Table 91. Getwell Oncology Company Details
Table 92. Getwell Oncology Business Overview
Table 93. Getwell Oncology Imatinib Mesylate Tablets Product
Table 94. Getwell Oncology Revenue in Imatinib Mesylate Tablets Business (2017-2022) & (US$ Million)
Table 95. Getwell Oncology Recent Developments
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imatinib Mesylate Tablets Market Share by Type: 2021 VS 2028
Figure 2. 100 mg Features
Figure 3. 400 mg Features
Figure 4. Global Imatinib Mesylate Tablets Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Imatinib Mesylate Tablets Report Years Considered
Figure 8. Global Imatinib Mesylate Tablets Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Imatinib Mesylate Tablets Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Imatinib Mesylate Tablets Market Share by Region: 2021 VS 2028
Figure 11. Global Imatinib Mesylate Tablets Market Share by Players in 2021
Figure 12. Global Top Imatinib Mesylate Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Tablets as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Imatinib Mesylate Tablets Revenue in 2021
Figure 14. North America Imatinib Mesylate Tablets Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2028)
Figure 16. North America Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2028)
Figure 17. North America Imatinib Mesylate Tablets Market Size Share by Country (2017-2028)
Figure 18. United States Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Imatinib Mesylate Tablets Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2028)
Figure 22. Europe Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2028)
Figure 23. Europe Imatinib Mesylate Tablets Market Size Share by Country (2017-2028)
Figure 24. Germany Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Imatinib Mesylate Tablets Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Imatinib Mesylate Tablets Market Size Share by Region (2017-2028)
Figure 34. China Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Imatinib Mesylate Tablets Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Imatinib Mesylate Tablets Market Size Share by Country (2017-2028)
Figure 44. Mexico Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Imatinib Mesylate Tablets Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Imatinib Mesylate Tablets Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Imatinib Mesylate Tablets Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Imatinib Mesylate Tablets Market Size Share by Country (2017-2028)
Figure 50. Turkey Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Imatinib Mesylate Tablets Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 54. Hikma Pharmaceuticals Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 55. Apotex Inc Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 56. Sun Pharmaceutical Industries Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 57. Lupin Limited Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 58. Natco Pharma Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 59. Getwell Oncology Revenue Growth Rate in Imatinib Mesylate Tablets Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---